ACHE and Cognitive impairment: Acetylcholinesterase (AChE) inhibitors are employed for patients with mild cognitive impairment or mild dementia stage disease (stage 4 based on FDA classification) to impede ACh degradation and, in turn, boost neural cell function by increasing ACh levels (Akıncıoğlu and Gülçin, 2020).